Skip to main content

Table 2 Patient and treatment characteristics

From: Dosing practice of low molecular weight heparins and its efficacy and safety in cardiovascular inpatients: a retrospective study in a Chinese teaching hospital

Patient characteristics

Data

Age, y

63.8 ± 11.4

 ≥75 years, n (%)

65 (20.8)

Female, n (%)

77 (24.7)

Body mass index

23.8 ± 3.2

Weight, kg

66.8 ± 10.9

Diagnosis, n (%)

 

 ST-segment elevation myocardial infarction

53 (17.0)

Unstable angina/Non ST-segment elevation Myocardial infarction

183 (58.6)

 Atrial fibrillation

67 (21.5)

 Deep vein thrombosis

9 (2.9)

Concurrent medical conditions, n (%)

 

 Hypertension

194 (62.2)

 Diabetes mellitus

69 (22.1)

Severe renal insufficient, n (%)

7 (2.2)

Creatinine clearance, ml/min

83.1 ± 27.8

Treatment variables, n (%)

 

 Cardiac catheterization

26 (8.3)

 Percutaneous coronary intervention

195 (62.5)

 Radiofrequency catheter ablation

44 (14.1)

Length of hospital stay, d

8.9 ± 5.8